Application value of portal vein flow velocity after different interventions on rebleeding in patients with hepatitis B cirrhosis complicated with esophageal and gastric variceal bleeding

Objective To investigate the predictors of rebleeding three months after treatment of esophageal and gastric variceal bleeding(EGVB)in patients with hepatitis B cirrhosis and the effects of different treatments on rebleeding.Methods From January 2018 to January 2020,the hepatitis B cirrhosis patients with first onset of EGVB in the First Hospital of Lanzhou University were enrolled and followed up for three months.